Home > Insider Trading > Filing (0001752864-20-000001)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1739426	Osmotica Pharmaceuticals Plc	OSMT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1752864	Ltd Altchem	Karaiskaki 6 City House Limassol G4 3032		No	No	Yes	No
1753129	Orbit Co-Invest A-1 Llc	895 Sawyer Road Marietta GA 30062		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2020-01-13	1,250,000	$5.00	22,485,297	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	1,182,243	Indirect	By Self as Sole Manager of Orbit Co-Invest A-1 LLC

Footnotes

The acquisition of Ordinary Shares reported on this Form 4 (the "Acquired Shares") was made pursuant to an underwritten public offering of Ordinary Shares by Osmotica Pharmaceuticals plc (the "Issuer"). In connection with such offering, the underwriters reimbursed the Issuer for any discounts and commissions payable by the Issuer with respect to the Acquired Shares (the "Discount"). The Issuer in turn paid a fee equal to the amount of the Discount to Altchem Limited totaling $406,250 (the "Fee"), or $0.325 per share. The $5.00 per share price does not reflect payment of the Fee to Altchem Limited.
Represents shares of the Issuer held by Orbit Co-Invest A-1 LLC. Altchem Limited is the sole manager of Orbit Co-Invest A-1 LLC. As a result, Altchem Limited may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest A-1 LLC. Altchem Limited disclaims beneficial ownership of such shares, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.